CTEGD names travel fund for Daniel G. Colley

NEWS

CTEGD names travel fund for Daniel G. Colley

Dan Colley teaching

Dr. Dan Colley with students (photo credit: Andrew Tucker)

One day Daniel Colley raised his hand to volunteer, setting in motion five decades of scientific adventures. It was 1969, and Colley’s postdoctoral adviser, ByronWaksman, a renowned immunologist at Yale University School of Medicine, had stepped into the laboratory and asked if anyone wanted to go to Brazil. Colley, today a UGA immunologist and Fellow of the American Association for the Advancement of Science, became fascinated by schistosomiasis, a parasitic worm infection plaguing poverty-stricken communities in sub-Saharan Africa and around the world.

After his Brazil sojourn, Colley arrived at Vanderbilt University in 1971 to begin setting up a lab and a career-long effort to understand the immunological paradox of schistosomiasis. In 1992, he joined the Centers for Disease Control and Prevention (CDC) and a year later was promoted to director of the Division of Parasitic Diseases. After retiring from the CDC, he arrived at UGA in 2001 as professor of microbiology and director of the Center for Tropical and Emerging Global Diseases. During the past decade, Colley has been director of UGA’s Schistosomiasis Consortium for Operational Research and Evaluation (SCORE). In June 2020, Colley retired from the University of Georgia. He has been named Professor Emeritus.

That trip to Brazil was instrumental in shaping Colley’s career. As a mentor, he is passionate about providing the same opportunity to new scientists. Early in his career at UGA, he established the Training Innovations in Parasitological Studies (TIPS) fellowship through funding from the Ellison Medical Foundation, funding that has since ended. In honor of Colley’s commitment to understanding diseases of poverty and training the next generation of scientists, the Center for Tropical and Emerging Global Diseases is establishing the Daniel G. Colley Training in Parasitology Fund to continue his legacy.

 

Tags:
,